Agenus Inc. (AGEN) financial statements and ratios from SEC XBRL: revenue $114.20M (TTM), net margin -2.7%, revenue growth 10.4% YoY, P/E 2.4. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $114.20M |
| Net Margin | -2.7% |
| Revenue Growth (YoY) | 10.4% |
| EPS Growth (YoY) | -100.0% |
| FCF Growth (YoY) | -51.4% |
| P/E Ratio | 2.4 |
| EV / EBITDA | 7.8 |
| Price / Sales | 2.55 |
| FCF Yield | -59.3% |
| Altman Z-Score | -13.90 (distress) |
| Piotroski F-Score | 3/9 |
| Sector P/E (Healthcare) | 21.7 |
AGEN overview · AGEN earnings · AGEN KPIs · AGEN investor relations · AGEN ownership · AGEN peers · AGEN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.